ES2134409T3 - Formulaciones supresoras frente a las metastasis hepaticas de los tumores. - Google Patents

Formulaciones supresoras frente a las metastasis hepaticas de los tumores.

Info

Publication number
ES2134409T3
ES2134409T3 ES95302003T ES95302003T ES2134409T3 ES 2134409 T3 ES2134409 T3 ES 2134409T3 ES 95302003 T ES95302003 T ES 95302003T ES 95302003 T ES95302003 T ES 95302003T ES 2134409 T3 ES2134409 T3 ES 2134409T3
Authority
ES
Spain
Prior art keywords
tumors
suppressive
formulations against
hepatic metastasis
against hepatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95302003T
Other languages
English (en)
Inventor
Tetsuya Toge
Toshihiro Hirai
Akihiro Yoshimoto
Kenichi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2134409T3 publication Critical patent/ES2134409T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN ACIDO FOSFORICO DIESTER DE FORMULA (EN LA QUE R1 Y R2 SON IGUALES ENTRE SI O DIFERENTES DEL OTRO Y REPRESENTAN HIDROGENO O METILO) Y SALES FARAMACOLOGICAMENTE ACEPTABLES DEL MISMO QUE SUPRIMEN LA METASTASIS HEPATICA DE LOS TUMORES Y LA ELEVACION DEL PEROXIDO LIPIDO DEL HIGADO.
ES95302003T 1994-03-29 1995-03-24 Formulaciones supresoras frente a las metastasis hepaticas de los tumores. Expired - Lifetime ES2134409T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5867194 1994-03-29
JP24016794 1994-10-04

Publications (1)

Publication Number Publication Date
ES2134409T3 true ES2134409T3 (es) 1999-10-01

Family

ID=26399697

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95302003T Expired - Lifetime ES2134409T3 (es) 1994-03-29 1995-03-24 Formulaciones supresoras frente a las metastasis hepaticas de los tumores.

Country Status (7)

Country Link
US (1) US5552389A (es)
EP (1) EP0674904B1 (es)
KR (1) KR950032257A (es)
AT (1) ATE183394T1 (es)
CA (1) CA2145229A1 (es)
DE (1) DE69511448T2 (es)
ES (1) ES2134409T3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
EP1379231A2 (en) 2001-04-06 2004-01-14 Cytorex Biosciences, Inc. Pharmacologically active strong acid solutions
MXPA04000654A (es) 2001-07-27 2004-03-19 Vital Health Sciences Pty Ltd Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
RU2477136C2 (ru) 2004-03-03 2013-03-10 Вайтал Хэлф Сайнсис Пти Лтд Алкалоидные составы
AU2006220247B2 (en) * 2005-03-03 2011-08-25 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
JP2008531602A (ja) * 2005-03-03 2008-08-14 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗癌特性を有する化合物
RU2428973C2 (ru) * 2005-03-03 2011-09-20 Вайтал Хэлф Сайнсис Пти Лтд Составы, обладающие липидопонижающими свойствами
US9168216B2 (en) 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CA2794734C (en) 2010-03-30 2017-12-12 Phosphagenics Limited Transdermal delivery patch
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62145019A (ja) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk 抗炎症剤
JPH02229169A (ja) * 1989-03-01 1990-09-11 Takeda Chem Ind Ltd ピラゾロン誘導体
JPH02229168A (ja) * 1989-03-01 1990-09-11 Takeda Chem Ind Ltd ピラゾロン誘導体

Also Published As

Publication number Publication date
EP0674904B1 (en) 1999-08-18
KR950032257A (ko) 1995-12-20
DE69511448T2 (de) 2000-04-27
EP0674904A1 (en) 1995-10-04
US5552389A (en) 1996-09-03
ATE183394T1 (de) 1999-09-15
DE69511448D1 (de) 1999-09-23
CA2145229A1 (en) 1995-09-30

Similar Documents

Publication Publication Date Title
ES2183331T3 (es) Inhibidores de sulfamida-metaloproteasa.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
ES8504140A1 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
ES2104673T3 (es) Hidroximetil(metilenciclopentil)purinas y pirimidinas.
ES2193508T3 (es) Ftalizinonas.
FR2698543B1 (fr) Nouvelles compositions à base de taxoides.
ES2191183T3 (es) Derivados 6,6- o 6,7-biciclicos que contienen pirido o pirimido sustituidos.
ES2152414T3 (es) Dihidrobenzofuranos.
ES2071169T3 (es) 1-indolilalquil-4-(alcoxi-pirimidinil)piperazinas.
AR025796A1 (es) Quinazolinonas
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2062215T3 (es) Derivados aminoalcoxibencenicos sustituidos.
ES452200A1 (es) Un procedimiento para la preparacion de nuevos derivados de pipendina.
AR030537A1 (es) Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2191109T3 (es) Inhibidores de proteasas de guanidino.
ES2111715T3 (es) Marcadores extraibles mediante una base para productos petroliferos.
PA8466101A1 (es) Agentes terapeuticos
ES2182021T3 (es) Oxazolinas artropodicidas.
PA8477601A1 (es) Inhibidores de las fkbp
ES2042726T3 (es) Beta-alquilmelatoninas.
ES2093286T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2174919T3 (es) Quinoxalinas y medicamentos a base de las mismas.
ATE118500T1 (de) Phospholipidderivate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 674904

Country of ref document: ES